Location
United Kingdom, Europe
Cheque size
$15M - $30M
Investment Stage
Pre Seed
Seed
Focus Areas
Health IT
Health & Hospital Services
BioTech
Pharmaceuticals
Medical Devices
About Investor
Genghis Lloyd-Harris is an Investor-in-Residence at Cancer Research Horizons and a Senior Advisor at Abingworth, where he previously served as a Partner. A physician-scientist with over 30 years of experience in finance and venture capital, he supports the evaluation and development of early-stage cancer ventures. His expertise spans biopharmaceuticals, clinical development, life science tools, and medical devices.
Previous investments
Nouscom
49M |2017
GenSight Biologics
36M |2015
42M |2013
Wilson Therapeutics
40M |2014
Similar Investors
TM
Tom Maughan
United Kingdom, Europe
$1M - $100M
Seed
,Series A
,FL
Fabio Longo
United Kingdom, Europe
$1M - $100M
Seed
,Series A
,RM
Rodolphe Menegaux
France, Europe
$1M - $20M
Seed
,Series A
,AS
Alex Sainty
United Kingdom, Europe
$7K - $30M
Pre Seed
,Seed
,AB
Anas Biad
United Kingdom, Europe
$10M - $200M
Seed
,Series A
,AR
Andre Ronsoehr
United Kingdom, Europe
$250K - $25M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
